This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Determine feasibility of FearLess recruitment
Timeframe: 1 Day
Determine the feasibility of FearLess intervention- Data collection procedures
Timeframe: 12 Weeks
Determine the acceptability of FearLess intervention- Attendance
Timeframe: 12 Weeks
Determine the acceptability of FearLess intervention- Retention Rate
Timeframe: 12 Weeks
Determine the acceptability of FearLess intervention- Satisfaction
Timeframe: 12 Weeks
Determine the acceptability of FearLess intervention- Satisfaction- Recommendation
Timeframe: 12 Weeks